Vyvanse approved to treat adults with ADHD

Article

Shire plc's Vyvanse can now be treated not only among children but also adults.

Approved in July 2007 to treat attention deficit hyperactivity disorder (ADHD) in kids six to 12 years of age, Shire plc's

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.